IFS Capital Limited (SGX:I49)

Market Cap	48.88M
Revenue (ttm)	54.82M
Net Income (ttm)	2.73M
Shares Out	375.97M
EPS (ttm)	0.01
PE Ratio	18.02
Forward PE	n/a
Dividend	0.01 (3.85%)
Ex-Dividend Date	May 6, 2025

Volume	10,000
Average Volume	70,155
Open	0.1280
Previous Close	0.1310
Day's Range	0.1280 - 0.1300
52-Week Range	0.1010 - 0.1360
Beta	0.36
RSI	50.88
Earnings Date	Aug 8, 2025

About Blueprint Medicines

IFS Capital Limited, together with its subsidiaries, provides commercial, alternative, and structured finance services in Singapore, Thailand, Malaysia, and Indonesia. It operates in four segments: Credit Financing, Insurance, Private Equity and Other Investments, and Fund Management. The company offers factoring, accounts receivable financing, trade financing, asset-based financing loans, working capital, leasing, and hire purchase services, as well as credit financing and consumer loans; and issues performance bonds and guarantees, domestic m...

• Industry: Miscellaneous business Credit Institutions
• Founded: 1987
• Employees: 267
• Stock Exchange: Singapore Exchange
• Ticker Symbol: I49

Financial Performance

In 2024, IFS Capital's revenue was 52.31 million, an increase of 38.30% compared to the previous year's 37.82 million. Earnings were 1.89 million, a decrease of -45.07%.